• Portfolio growth performance: Core all-weather brands grew around 14% in Q4 and 16% to 17% for the full year, while seasonal brands Glucon-D and Nycil fell about 9% due to adverse weather patterns. The recently acquired European business, Comfort Click, posted 31% reported growth and 27% to 28% growth in constant currency for the quarter.
• EBITDA margin targets: Base business EBITDA margins are projected to expand from 14%–14.5% to 17%–18% over the next few years via gross margin improvements, cost optimization, and operating leverage. Acquired business Comfort Click will continue to operate at 14% to 15% margins as management prioritizes scaling the business.
• Acquisition pipeline strategy: Management continues to target opportunities in food, nutrition, and personal care, typically evaluating spaces for 3 to 4 years before transacting. No new acquisitions are specifically expected in the next 1 to 2 years unless a compelling opportunity arises.
• GLP-1 market tailwind: Management views the rising adoption of GLP-1 weight-loss drugs as a favorable demand driver rather than a headwind for the protein portfolio. Products like RiteBite Max Protein and Complan are positioned to benefit as consumers seek protein to mitigate muscle mass loss during weight reduction.